Brevital Sodium (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Brevital Sodium drug offered from Par Pharmaceutical, Inc.. This Barbiturate [EPC],Barbiturates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | methohexital sodium |
SUBSTANCE NAME: | METHOHEXITAL SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Barbiturate [EPC],Barbiturates [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS; RECTAL |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2007-11-01 |
END MARKETING DATE: | 0000-00-00 |
Brevital Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Brevital Sodium from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2007-11-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42023-105_e387f9d3-5b2e-4359-88ab-1ce750c42c66 |
PRODUCT NDC: | 42023-105 |
APPLICATION NUMBER: | NDA011559 |
Other METHOHEXITAL SODIUM Pharmaceutical Manufacturers / Labelers: